dc.contributor.author |
Atakov S.S., Okhunov A.O., Bobokulova Sh.A., Kasimov U.K., Bobabekov A.R. |
|
dc.date.accessioned |
2022-10-12T14:46:33Z |
|
dc.date.available |
2022-10-12T14:46:33Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
2181-3175 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/3814 |
|
dc.description.abstract |
Suppurative diseases of the lungs are topical issues of pulmonology that require
detailed study due to the difficulties of diagnosis and high mortality of patients. This is due to a
number of objective and subjective reasons, in particular, such as the widespread use of antibiotic-
resistant microflora, which is especially important when antibiotics are prescribed unreasonably,
even with a mild form of COVID -19. This, of course, affects COVID patients, who already have
reduced immunity. The question of the exact mechanism of development of purulent complications of
the lungs after or during infection with COVID -19 remains open. Clinical and radiological signs of
a lung abscess often resemble the symptoms of pneumonia, however, antibacterial and symptomatic
therapy have differences. With gangrene of the lung, the increase in intoxication syndrome can be
gradual, which reduces the doctor's alertness regarding the most severe disease and causes inade-
quate therapy. Comprehensive diagnostic measures, knowledge of the main clinical, instrumental and
laboratory parameters are necessary for all physicians. |
en_US |
dc.language.iso |
other |
en_US |
dc.publisher |
Toshkent tibbiyot akademiyasi - O'quv va ilmiy tibbiyot jurnali |
en_US |
dc.subject |
: acute lung abscesses, lung gangrene, diagnostics, microbiology, sparing methods of treatment |
en_US |
dc.title |
DIFFICULT ASPECTS OF TREATMENTS PATIENTS WITH ACUTE LUNG ABSCESSES WHO SURVIVED COVID -19 |
en_US |
dc.type |
Article |
en_US |